Cigna Corp
$ 281.00
-0.77%
24 Feb - close price
- Market Cap 75,062,354,000 USD
- Current Price $ 281.00
- High / Low $ 284.72 / 277.17
- Stock P/E 12.67
- Book Value 153.73
- EPS 22.17
- Next Earning Report 2026-04-30
- Dividend Per Share $6.04
- Dividend Yield 2.13 %
- Next Dividend Date 2026-03-19
- ROA 0.04 %
- ROE 0.15 %
- 52 Week High 344.64
- 52 Week Low 238.17
About
Cigna is an American multinational managed healthcare and insurance company based in Bloomfield, Connecticut. Its insurance subsidiaries are major providers of medical, dental, disability, life and accident insurance and related products and services, the majority of which are offered through employers and other groups (e.g. governmental and non-governmental organizations, unions and associations).
Analyst Target Price
$332.62
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-01-28 | 2025-10-30 | 2025-07-31 | 2025-05-02 | 2025-01-30 | 2024-10-31 | 2024-08-01 | 2024-05-02 | 2024-02-02 | 2023-11-02 | 2023-08-03 | 2023-05-05 |
| Reported EPS | 8.08 | 7.83 | 7.2 | 6.74 | 6.64 | 7.51 | 6.72 | 6.47 | 6.79 | 6.77 | 6.13 | 5.41 |
| Estimated EPS | 7.9 | 7.69 | 7.15 | 6.35 | 7.82 | 7.25 | 6.41 | 6.22 | 6.54 | 6.67 | 6.02 | 5.22 |
| Surprise | 0.18 | 0.14 | 0.05 | 0.39 | -1.18 | 0.26 | 0.31 | 0.25 | 0.25 | 0.1 | 0.11 | 0.19 |
| Surprise Percentage | 2.2785% | 1.8205% | 0.6993% | 6.1417% | -15.0895% | 3.5862% | 4.8362% | 4.0193% | 3.8226% | 1.4993% | 1.8272% | 3.6398% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-04-30 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | 7.35 |
| Currency | USD |
Previous Dividend Records
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-03-19 | 2025-12-18 | 2025-09-18 | 2025-06-18 | 2025-03-20 | 2024-12-19 | 2024-09-19 | 2024-06-20 | 2024-03-21 | 2023-12-21 |
| Amount | $1.56 | $1.51 | $1.51 | $1.51 | $1.51 | $1.4 | $1.4 | $1.4 | $1.4 | $1.23 |
Next Dividend Records
| Dividend per share (year): | $6.04 |
| Dividend Yield | 2.13% |
| Next Dividend Date | 2026-03-19 |
| Ex-Dividend Date | 2026-03-05 |
Recent News: CI
2026-02-24 20:52:35
Keystone Financial Group recently increased its holdings in the VictoryShares Free Cash Flow ETF (VFLO) by purchasing 269,496 shares, an estimated $10.34 million transaction. This move reflects a strategy to invest in companies with strong free cash flow, which are well-positioned to navigate economic downturns and continue growth. As of December 31, 2025, Keystone now holds 1,047,375 VFLO shares valued at $41.25 million, representing 3.05% of its 13F AUM.
2026-02-24 17:50:20
Geisinger has appointed Jeremy Gaskill, a former Humana executive, as the new president of Geisinger Health Plan and executive vice president of insurance operations for Geisinger. Gaskill, with over two decades of experience at Humana managing Medicare and government business lines, will focus on transforming healthcare and building on GHP's legacy of comprehensive coverage for Pennsylvanians. He takes over from Karen Murphy, who is transitioning out of the role.
2026-02-24 15:35:12
UBS has increased its price target for Stryker (SYK) to $400 from $386, while reiterating a Neutral rating on the stock. This adjustment comes as Stryker, a leading medical equipment manufacturer, continues to operate in the medical surgery, neurotechnology, and orthopaedics sectors. The company recently launched new products, including Synchfix?? EVT and the T2 Alpha Humerus Nailing System.
2026-02-24 04:51:18
DaVita Inc. has completed over $5.6 billion in share buybacks, significantly reducing its share count. This move, combined with CEO Javier Rodriguez's focus on long-term care and technology, aims to reshape the company's investment narrative. While buybacks could amplify future earnings per share, underlying operational risks and reimbursement pressures remain.
2026-02-24 04:00:38
Truist has raised its price target for Cigna (CI) to $350 from $320, reiterating a Buy rating after the company's Q4 results and 2026 outlook provided clearer visibility into its growth trajectory. Cigna's CEO, David Cordani, highlighted an 11% increase in adjusted revenue and 9% growth in adjusted earnings per share for the full year, along with strategic repositioning including increased investment in Shields Health Solutions and a Medicare business divestiture. The company also resolved Federal Trade Commission matters related to pharmacy benefits and launched a rebate-free pharmacy benefit model.
2026-02-23 21:21:40
Brighthouse Financial, Inc. (BHF) reported its Q4 adjusted earnings per share at $3.70. The company, an annuities and life insurance provider, recently had its stockholders approve a merger proposal. This financial update includes details about its Q4 2025 earnings release.
